TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank76
3Y CAGR-19.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-19.7%/yr
Quarterly compound
Percentile
P76
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 33.03% |
| Q3 2025 | 49.33% |
| Q2 2025 | -62.70% |
| Q1 2025 | 21.17% |
| Q4 2024 | 47.39% |
| Q3 2024 | 19.18% |
| Q2 2024 | -23.51% |
| Q1 2024 | -22.80% |
| Q4 2023 | 59.15% |
| Q3 2023 | -134.54% |
| Q2 2023 | 12.06% |
| Q1 2023 | -26.39% |
| Q4 2022 | 63.68% |
| Q3 2022 | -182.65% |
| Q2 2022 | 23.57% |
| Q1 2022 | -1455.39% |
| Q4 2021 | -86.48% |
| Q3 2021 | 24.90% |
| Q2 2021 | -136.20% |
| Q1 2021 | 69.62% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |